The risk of peptic ulcer disease, pre-malignant gastric pathology (intestinal metaplasia and gastric atrophy) and ultimately distal gastric adenocarcinoma have a higher incidence in patients infected with cagA-positive strains when compared with persons infected with cagA-negative strains [13,14]. This evidence concerns the gene S100A8 and peptic ulcer disease.